James H. Sabry, CEO at CYTOKINETICS INC (CYTK), sold 7,000 shares at $8.65 ($61K) on 2007-01-03, disclosed to the SEC on 2007-01-05.
Scheduled sale ($61k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.65 | 3,158 | $27K | 44.8% |
| 2 | $8.66 | 100 | $866 | 1.4% |
| 3 | $8.67 | 500 | $4K | 7.1% |
| 4 | $8.68 | 700 | $6K | 10.0% |
| 5 | $8.69 | 100 | $869 | 1.4% |
| 6 | $8.70 | 242 |
| $2K |
| 3.5% |
| 7 | $8.71 | 200 | $2K | 2.9% |
| 8 | $8.80 | 2,000 | $18K | 28.9% |
| Total | $8.70 avg | 7,000 | $61K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |